Loading...
PAVmed Inc (PAVM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is severely negative, with significant revenue, net income, and EPS declines. Technical indicators suggest a bearish trend, and there are no positive trading signals or catalysts to support a buy decision. Additionally, there is no recent news, analyst ratings, or significant insider or hedge fund activity to provide confidence in the stock's future performance.
The technical indicators for PAVM are bearish. The MACD histogram is negative and contracting, the RSI is neutral at 56.986, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the key pivot level of 9.779, with resistance levels at 10.749 and 11.348, and support levels at 8.808 and 8.209.

NULL identified. There are no recent news events, analyst upgrades, or significant insider/hedge fund activity to act as positive catalysts.
Additionally, the stock is in a bearish technical trend, and there are no significant trading signals or positive sentiment from options data.
In Q3 2025, PAVmed Inc reported a revenue drop of 99.50% YoY to $5,000, a net income drop of 109.84% YoY to -$6,328,000, and an EPS decline of 120.38% YoY to -8.81. Gross margin increased to -1000, up 2032.65% YoY, but remains negative.
No data available for analyst ratings or price target changes.